Department of Paediatric Nephrology, Hepatology & Metabolic Diseases, Hannover Medical School, Hannover, Germany.
Department of Paediatrics I, University Children's Hospital, Heidelberg, Germany.
Eur J Hum Genet. 2019 Dec;27(12):1783-1790. doi: 10.1038/s41431-019-0460-z. Epub 2019 Jul 30.
Transition in medical care is a high-risk period in adolescence and young adulthood. To date, data on transition policy, its application in practice, and transition procedures in patients with rare, hereditary kidney diseases in Europe is scarce. An online survey was developed and was distributed within the paediatric centres of the European Reference Network for Rare Kidney Diseases (ERKNet) aiming to assess the transition-relevant structures from the providers' perspectives. Its items were based on the consensus statement on transition published by the International Society of Nephrology (ISN) and the International Paediatric Nephrology Association (IPNA) in 2011. Forty-six paediatric experts based at 28/32 ERKNet university hospitals participated. Annually, a median number of 14 patients (1-80) are transferred to adult based care. One centre continued to care for paediatric kidney transplant recipients throughout their entire lifespan. Choosing this option terminated the survey and no further data was obtained from this centre. 29/45 experts confirmed the application of an-at least unwritten-transition procedure (64%). Transition clinics are offered by 23 experts. Most physicians (40%) transfer patients at age 18-19, 10 experts at age <18. Most physicians transfer the patients to a university hospital and/or a community hospital. The transition guidelines have been implemented in ERKNet centres only partly and with huge heterogeneity. Implementation of transition tools and structures within ERKNet could improve health of children with hereditary kidney diseases. Adherence of experts to the transition-guidelines was significantly correlated with gross national income of their countries.
医疗过渡期是青少年和青年时期的高风险期。迄今为止,欧洲有关罕见遗传性肾脏疾病患者的过渡政策、其在实践中的应用以及过渡程序的数据非常有限。我们开发了一项在线调查,并在欧洲罕见肾脏疾病参考网络(ERKNet)的儿科中心内分发,旨在从提供者的角度评估与过渡相关的结构。其项目基于国际肾脏病学会(ISN)和国际儿科肾脏病学会(IPNA)于 2011 年发布的过渡共识声明。28/32 家 ERKNet 大学医院的 46 名儿科专家参与了调查。每年,有中位数 14 名(1-80 岁)患者从儿科转为成人护理。一家中心继续为整个生命周期的儿科肾移植受者提供护理。选择此选项会终止调查,并且不会再从该中心获得进一步的数据。29/45 名专家确认至少采用了一种未书面化的过渡程序(64%)。23 名专家提供过渡诊所。大多数医生(40%)在 18-19 岁时将患者转移,10 名医生在<18 岁时转移。大多数医生将患者转移到大学医院和/或社区医院。过渡指南仅在 ERKNet 中心部分实施,而且具有很大的异质性。在 ERKNet 内实施过渡工具和结构可以改善遗传性肾脏疾病儿童的健康状况。专家对过渡指南的遵循与他们所在国家的国民总收入显著相关。